References
Martin AP, Aushev VN, Zalcman G, Camonis JH (2020) The STK38-XPO1 axis, a new actor in physiology and cancer. Cell Mol Life Sci. https://doi.org/10.1007/s00018-020-03690-w
Martin AP, Jacquemyn M, Lipecka J, Chhuon C, Aushev VN, Meunier B, Singh MK, Carpi N, Piel M, Codogno P, Hergovich A, Parrini MC, Zalcman G, Guerrera IC, Daelemans D, Camonis JH (2019) STK38 kinase acts as XPO1 gatekeeper regulating the nuclear export of autophagy proteins and other cargoes. EMBO 20(11):e48150. https://doi.org/10.15252/embr.201948150 (Epub 23 Sep 2019)
The International Mouse Phenotyping Consortium. Accessed Dec 2020. https://www.mousephenotype.org/data/genes/MGI:2144013#phenotypesTab
Cornils H, Stegert MR, Hergovich A, Hynx D, Schmitz D, Dirnhofer S et al (2010) Ablation of the kinase NDR1 predisposes mice to the development of T cell lymphoma. Sci Signal 3(126):47
Sendino M, Omaetxebarria MJ, Rodríguez JA (2018) Hitting a moving target: inhibition of the nuclear export receptor XPO1/CRM1 as a therapeutic approach in cancer. Cancer Drug Resist 1:139–163
Azmi AS, Uddin MH, Mohammad RM (2020) The nuclear export protein XPO1—from biology to targeted therapy. Nat Rev Clin Oncol. https://doi.org/10.1038/s41571-020-00442-4
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Rodriguez, J.A. The “STK38-XPO1 axis”: its general relevance and mechanistic underpinnings remain to be further characterized. Cell. Mol. Life Sci. 78, 4451–4452 (2021). https://doi.org/10.1007/s00018-021-03778-x
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00018-021-03778-x